-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Madrigal Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- Madrigal Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $168K, a 35.5% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $527K, a 12.8% increase from 2022.
- Madrigal Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $467K, a 15.3% increase from 2021.
- Madrigal Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $405K, a 14% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)